To the Editor: The report of the 2008 recommendations of the International AIDS Society–USA Panel by Dr Hammer and colleagues1 provides current standards for the complex decision-making around antiretroviral treatment for AIDS. The article discussed when to start treatment in special populations, including persons with or at risk of specific opportunistic diseases and coinfections (hepatitis B and hepatitis C virus), patients with human immunodeficiency virus (HIV)–associated nephropathy, and pregnant women.
Zirulnik JL. Therapy Recommendations for HIV-Associated Neurocognitive Disorders. JAMA. 2008;300(21):2482-2483. doi:10.1001/jama.2008.733